Fig. 3
From: Role of macrophage-to-myofibroblast transition in chronic liver injury and liver fibrosis
MMT in the NAFLD and AFLD model. A Representative images of immunofluorescent multi-staining for macrophage marker F4/80 (Green) and myofibroblast marker α-SMA (purple) in NAFLD model. B Quantitative data for the expression of F4/80 and α-SMA, and co-expression of F4/80 and α-SMA in NAFLD model. C Representative images of immunofluorescent multi-staining for macrophage marker F4/80 (Green) and myofibroblast marker α-SMA (purple) in AFLD model. D Quantitative data for the expression of F4/80 and α-SMA, and co-expression of F4/80 and α-SMA in AFLD model. All the data were shown as the mean ± s.d. *P < 0.05 and **P < 0.01vs. Normal group. Scale bar, 20 µm